| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10897423 | Cancer Epidemiology | 2015 | 5 Pages |
Abstract
The results of this meta-analysis support the utility of PAX1 methylation as an auxiliary biomarker in cervical cancer screening. PAX1 could be used effectively to increase the specificity of HPV DNA by detecting women with more advanced cervical abnormalities.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Christos Nikolaidis, Evangelia Nena, Maria Panagopoulou, Ioanna Balgkouranidou, Makrina Karaglani, Ekaterini Chatzaki, Theodoros Agorastos, Theodoros C. Constantinidis,